Denis L - Search Results

1

A phase-II study of neoadjuvant chemotherapy in T3-4N0-XM0 transitional cell carcinoma of the bladder: a preliminary analysis.

Splinter TA, Schröder FH, Denis L, Newling D, Jacqmin D, Hall RR, de Pauw M. Splinter TA, et al. Among authors: denis l. Eur Urol. 1988;14 Suppl 1:24-6. doi: 10.1159/000473035. Eur Urol. 1988. PMID: 3181236 No abstract available.

2

Neoadjuvant chemotherapy of invasive bladder cancer. The prognostic value of local tumor response.

Splinter TA, Denis L, Scher HI, Schröder FH, Dalesio O. Splinter TA, et al. Among authors: denis l. Prog Clin Biol Res. 1989;303:541-7. Prog Clin Biol Res. 1989. PMID: 2675011 Clinical Trial. No abstract available.

3

Neoadjuvant chemotherapy in T3-4 N0-X M0 transitional cell carcinoma of the bladder. Problems of clinical and pathological evaluation of response.

Splinter TA, ten Kate FJ, Schröder FH, Denis L, Newling D, Jones WG, Jacqmin D, Boeken Kruger CG, Stoter G, de Voogt HJ, et al. Splinter TA, et al. Among authors: denis l. Prog Clin Biol Res. 1988;269:579-90. Prog Clin Biol Res. 1988. PMID: 3393555 No abstract available.

4

Combination chemotherapy with cisplatin and methotrexate in advanced transitional cell cancer of the bladder.

Stoter G, Splinter TA, Child JA, Fosså SD, Denis L, van Oosterom AT, de Pauw M, Sylvester R. Stoter G, et al. Among authors: denis l. J Urol. 1987 Apr;137(4):663-7. doi: 10.1016/s0022-5347(17)44168-1. J Urol. 1987. PMID: 3560318

5

Embolization and postinfarction nephrectomy in patients with primary metastatic renal adenocarcinoma.

Kurth KH, Debruyne FM, Hall RR, Denis L, Verbaes A, Bollack C, de Voogt HJ, de Pauw M, Silvester R. Kurth KH, et al. Among authors: denis l. Eur Urol. 1987;13(4):251-5. doi: 10.1159/000472789. Eur Urol. 1987. PMID: 3653165

6

The prognostic value of the pathological response to combination chemotherapy before cystectomy in patients with invasive bladder cancer. European Organization for Research on Treatment of Cancer--Genitourinary Group.

Splinter TA, Scher HI, Denis L, Bukowski R, Simon S, Klimberg I, Soloway M, Vogelzang NJ, van Tinteren H, Herr H. Splinter TA, et al. Among authors: denis l. J Urol. 1992 Mar;147(3):606-8. doi: 10.1016/s0022-5347(17)37318-4. J Urol. 1992. PMID: 1538438

7

Chemoresection in Ta-T1 bladder cancer. Members of the EORTC Genito-Urinary Group.

Bono AV, Hall RR, Denis L, Lovisolo JA, Sylvester R. Bono AV, et al. Among authors: denis l. Eur Urol. 1996;29(4):385-90. doi: 10.1159/000473784. Eur Urol. 1996. PMID: 8791042 Clinical Trial.

8

Update of EORTC clinical trials in prostate cancer. The EORTC Genito-Urinary Group.

Newling DW, Pavone Macaluse M, Smith P, de Voogt HJ, Robinson MR, Schroder FH, Denis L, Jones WG, de Pauw M, Sylvester R. Newling DW, et al. Among authors: denis l. Semin Urol. 1992 Feb;10(1):65-71. Semin Urol. 1992. PMID: 1565905 Review. No abstract available.

9

Orchidectomy vs. Zoladex plus flutamide in patients with metastatic prostate cancer. The EORTC GU Group.

Denis L, Smith PH, De Moura JL, Newling DW, Bono A, Keuppens F, Robinson M, Mahler C, Sylvester R, De Pauw M, et al. Denis L, et al. Eur Urol. 1990;18 Suppl 3:34-40. doi: 10.1159/000463978. Eur Urol. 1990. PMID: 2151274 Clinical Trial.

10

The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.

Splinter TA, Scher HI, Denis L, Bukowski R, Soloway M, Vogelzang N, Klimberg I, Dalesio O, Herr H. Splinter TA, et al. Among authors: denis l. Prog Clin Biol Res. 1990;353:219-24. Prog Clin Biol Res. 1990. PMID: 2217422 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

406 results

Search Page

Filters